Intelligent Bio Solutions addresses cybersecurity issues, keeps 510(k) submission on track for H2 2026 — TradingView News | #hacking | #cybersecurity | #infosec | #comptia | #pentest | #ransomware

Intelligent Bio Solutions resolved all cybersecurity and software review items ahead of a planned FDA 510(k) submission in H2 2026.

Key Highlights:

• Completed independent penetration testing and remediated all cybersecurity review items, reducing regulatory risk.
• 100% of medium-risk vulnerabilities fixed; low-risk issues cut from 11 to 2 with risk-based justifications provided.
• All 19 SBOM vulnerabilities resolved and documentation aligned with FDA guidance; third-party verification found no remaining issues.
• 510(k) package remains on track for calendar H2 2026, targeting codeine detection to enable U.S. market entry beyond forensic use.
• Manufacturing partnership expected to cut production costs >40% and improve gross margin by ~20 percentage points, supporting scalable launch.

Original SEC Filing: INTELLIGENT BIO SOLUTIONS INC. [ INBS ] – 8-K – Jul. 23, 2026